FY2025 EPS Estimates for U.S. Physical Therapy, Inc. (NYSE:USPH) Cut by Analyst

U.S. Physical Therapy, Inc. (NYSE:USPH) – Investment analysts at Barrington Research decreased their FY2025 earnings per share estimates for U.S. Physical Therapy in a report issued on Wednesday, October 9th. Barrington Research analyst M. Petusky now forecasts that the company will earn $2.50 per share for the year, down from their previous estimate of $2.85. Barrington Research currently has a “Outperform” rating and a $108.00 target price on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.58 per share. Barrington Research also issued estimates for U.S. Physical Therapy’s FY2026 earnings at $2.85 EPS.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The company had revenue of $167.19 million for the quarter, compared to the consensus estimate of $163.34 million. During the same period last year, the company earned $0.76 earnings per share. U.S. Physical Therapy’s revenue for the quarter was up 10.4% compared to the same quarter last year.

Other analysts have also recently issued reports about the company. Bank of America reissued a “neutral” rating and set a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st.

U.S. Physical Therapy Trading Up 3.6 %

USPH stock opened at $80.29 on Friday. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 0.28. U.S. Physical Therapy has a twelve month low of $76.18 and a twelve month high of $113.63. The company has a market cap of $1.21 billion, a P/E ratio of 65.28, a PEG ratio of 3.68 and a beta of 1.39. The business has a fifty day moving average of $84.09 and a 200-day moving average of $94.30.

Institutional Trading of U.S. Physical Therapy

A number of institutional investors have recently modified their holdings of the company. Canada Pension Plan Investment Board acquired a new position in shares of U.S. Physical Therapy during the 2nd quarter worth about $28,000. Innealta Capital LLC bought a new stake in shares of U.S. Physical Therapy in the second quarter valued at about $30,000. Quest Partners LLC grew its position in shares of U.S. Physical Therapy by 2,808.3% during the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after purchasing an additional 337 shares in the last quarter. Northwest Bank & Trust Co bought a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at approximately $37,000. Finally, Quarry LP raised its holdings in U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock valued at $48,000 after acquiring an additional 478 shares in the last quarter.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the transaction, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at $580,635. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares in the company, valued at $580,635. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were acquired at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the acquisition, the director now directly owns 18,904 shares in the company, valued at $1,627,445.36. This represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Investors of record on Friday, August 23rd were issued a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date was Friday, August 23rd. U.S. Physical Therapy’s dividend payout ratio is currently 143.09%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.